ATRC
AtriCure, Inc.
Key Financials
Gross Profit
$400.8M
↑ 15.3%
Revenue
$534.5M
↑ 14.9%
Net Income
$-11448000
↑ 74.4%
Total Assets
$654.2M
↑ 7.4%
Shareholders' Equity
$491.9M
↑ 6.7%
EPS (Diluted)
$-0.24
↑ 74.7%
Total Liabilities
$162.2M
↑ 9.4%
Operating Income
$-9447000
↑ 76.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 4/6/2026 | View on SEC |
| DEF 14A | 4/6/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/16/2026 | View on SEC |
| 144 | 3/12/2026 | View on SEC |
| 4 | 3/12/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ATRC |
| Company Name | AtriCure, Inc. |
| CIK | 1323885 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 513-755-4100 |